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ABSTRACT: The twin-arginine translocation (Tat) pathway is a protein
targeting system found in bacteria, archaea, and chloroplasts. Proteins are
directed to the Tat translocase by N-terminal signal peptides containing
SRRxFLK “twin-arginine” amino acid motifs. The key feature of the Tat
system is its ability to transport fully folded proteins across ionically sealed
membranes. For this reason the Tat pathway has evolved for the assembly of
extracytoplasmic redox enzymes that must bind cofactors, and so fold, prior
to export. It is important that only cofactor-loaded, folded precursors are
presented for export, and cellular processes have been unearthed that
regulate signal peptide activity. One mechanism, termed “Tat proofreading”,
involves specific signal peptide binding proteins or chaperones. The archetypal
Tat proofreading chaperones belong to the TorD family, which are dedicated
to the assembly of molybdenum-dependent redox enzymes in bacteria.
Here, a gene cluster was identified in the archaeon Archaeoglobus fulgidus
that is predicted to encode a putative molybdenum-dependent tetrathionate reductase. The gene cluster also encodes a TorD
family chaperone (AF0160 or TtrD) and in this work TtrD is shown to bind specifically to the Tat signal peptide of the TtrA
subunit of the tetrathionate reductase. In addition, the 3D crystal structure of TtrD is presented at 1.35 Å resolution and a
nine-residue binding epitope for TtrD is identified within the TtrA signal peptide close to the twin-arginine targeting motif.
This work suggests that archaea may employ a chaperone-dependent Tat proofreading system that is similar to that utilized by
bacteria.
T
he twin-arginine translocation (Tat) pathway is a protein
export system found in the cytoplasmic membranes of
many prokaryotes (bacteria and archaea) and in the thylakoid
membranes of plant chloroplasts.
1 The physiological function
of the Tat system is the transmembrane translocation of fully
folded proteins. Substrates are targeted to the Tat translocase
by N-terminal signal peptides bearing an SRRxFLK “twin-
arginine” amino acid motif.
2 Such Tat signal peptides have a
tripartite structure comprising a polar n-region of variable
sequence, followed by a hydrophobic h-region (15−25 amino
acid residues) and a more polar c-region (often positively
charged) that usually contains a protease cleavage site. The
twin-arginine motif is positioned at the boundary between the
n- and h-regions.
2
The Tat translocase itself is membrane-embedded and con-
tains a universally conserved TatC protein, which is involved in
signal peptide recognition,
3 a TatA-like protein that may form
the protein-conducting channel,
4−6 and, in some cases, a TatB
component that forms a complex with TatC.
3 The translocation
event is driven by the transmembrane electrochemical gradi-
ent,
7 and signal peptides are usually cleaved from substrates by
membrane-bound signal peptidases.
8
As a result of the ability of the Tat pathway to transport fully
folded proteins, the vast majority of traffic following this route
comprises enzymes that bind, and therefore fold around,
cofactors in the cell cytoplasm prior to translocation. Clearly,
premature export of immature cofactor-containing enzymes
must be avoided, and systems have been unearthed that
coordinate the assembly and export events. Using an alkaline
phosphatase reporter, Delisa et al.
9 suggested that the Tat
translocase itself may actively reject unfolded substrates. This
was termed “Tat quality control”; however, the molecular basis
of this phenomenon remains unresolved. In recent years, an
alternative system designed to regulate transport on the Tat
pathway by utilizing signal peptide-binding chaperones has
been described. In this case, the signal peptides of immature
Tat substrates are bound tightly by specific cytoplasmic
proteins in a process that is hypothesized to suppress Tat
transport until all other assembly processes are complete.
10
Once cofactor insertion and protein folding has occurred, the
signal peptide is released by the chaperone and is free to
interact with the Tat translocase in the membrane. This system
is termed “Tat proofreading”.
10
The archetypal Tat proofreading chaperones belong to the
TorD family.
10,11 These are peptide-binding proteins dedicated
to the assembly of molybdenum-dependent enzymes and in-
clude those required for biosynthesis of trimethylamine N-oxide
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reductases.
12−15 Crystal structures of TorD family proteins
show an α-helical fold arranged into two domains (N- and C-
terminal) connected by a “hinge”. The proteins exist as mono-
mers or domain-swapped homodimers where the N-domain of
one protomer packs onto the C-domain of another.
16 The
hinge is often partially or completely unstructured and flexible,
so many structures lack electron density for this region. This is
a problem since the most highly conserved motif in TorD
family proteins (EPxDH) is located within the hinge.
16 The
“DH” dipeptide is practically invariant and is essential for Tat
proofreading activity,
17 while biochemical and modeling studies
have suggested these residues play a direct role in signal peptide
recognition.
15,18 TorD family proteins usually bind exclusively
to one Tat signal peptide only, although one Salmonella chaper-
one has been shown to recognize three related Tat signal
peptides.
14 The molecular basis of peptide selectivity, or the
peptide binding-and-release mechanism, is not fully under-
stood, and the 3D structure of a signal peptide−chaperone
complex is not available for any TorD family protein.
In an attempt to make new breakthroughs in understanding
the Tat proofreading system in general, and the structure and
function of TorD family chaperones in particular, the genetics
of a number of microbes were studied. The hyperthermophilic
archaeon Archaeoglobus fulgidus was found to carry the genes
for several Tat-dependent reductases. One of those is a homo-
logue of the Salmonella enterica tetrathionate reductase, an
enzyme that has recently been implicated in the virulence of
that human pathogen.
19 Interestingly, a gene (Af0160) was
identified in the A. fulgidus ttr operon that would encode a
TorD family protein which we named TtrD (Figure 1A). This
observation suggests that assembly of these important enzymes
may require a Tat proofreading chaperone.
In this work it is demonstrated that the TtrD protein binds
directly to the twin-arginine signal peptide of the putative
catalytic subunit of the A. fulgidus tetrathionate reductase. The
binding epitope for TtrD on the signal peptide is identified as a
short 11-residue stretch partly overlapping the conserved Tat
motif. The high-resolution crystal structure of TtrD reveals a
monomeric protein with a fold similar to some TorD family
chaperones from bacteria. In this case, however, electron den-
sity corresponding to the hinge region is well-defined. This
work suggests that archaea employ a Tat proofreading system
during assembly of complex, cofactor-containing enzymes that
is identical to that of bacteria.
■ MATERIALS AND METHODS
Bacterial Strains and Growth Conditions. Bacterial
strains used in this study are listed in Table S1. E. coli strains
were routinely cultured in LB media, at 37 °C and with appro-
priate antibiotic selection (Amp 100 μg/mL, Cm 25 μg/mL,
and Kan 50 μg/mL). For SDS-resistance tests, SDS was added
to LB agar plates at 2% (w/v) final concentration.
Plasmids and Molecular Biology. Plasmids used in this
study are described in Table S1. All molecular biology was
performed according to standard procedures. A synthetic
ttrBACD operon was designed by back-translation of the
amino acid sequences of the TtrBACD (AF0157-AF0160)
Figure 1. A putative tetrathionate reductase (ttr) operon in Archaeoglobus fulgidus. (A) Schematic representation of the AF0157−AF0161 operon
from A. fulgidus. AF0157 (TtrB) is predicted to be an Fe−S protein, AF0158 (TtrC) is predicted to be an integral membrane protein with nine
transmembrane domains, AF0159 (TtrA) is predicted to encode a Tat-dependent molybdenum- or tungsten-dependent reductase with most
similarity to tetrathionate reductases from bacteria, TtrD is a member of the TorD family of signal peptide binding proteins, and Moe-A3 is a
member of a family of proteins required of Mo or W incorporation into a pterin cofactor. (B) Schematic representation of a synthetic ttrBACD
operon constructed in this study. Incorporated restriction sites are shown, and E. coli-biased ribosome binding sites are indicated by “R”. (C) A
cartoon of how the A. fulgidus tetrathionate reductase may be assembled in the cell membrane. The black squares represent [4Fe−4S] clusters, and
the white star represents the MGD cofactor. (D) 35S-Met pulse-labeling of the Ttr proteins expressed from the synthetic operon under the control of
the T7 promoter in pUNIPROM followed by SDS-PAGE and autoradiography. Derivatives of the pUNI-TtrBACD vector deleted for ttrD (ΔD),
ttrB (ΔB), ttrBC (ΔBC), and ttrAD (ΔAD) are indicated.
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using the online Backtranslation tool (Entelechon, Germany).
The sequence was also codon optimized for expression in
E. coli. These sequences were then assembled into the synthetic
operon in silico, with the concomitant introduction of ribosome
binding sites and restriction sites for convenient downstream
manipulation. Finally the complete 5.66 kbp sequence was
synthesized and supplied in the cloning vector pGH (Biomatik)
to yield pGH_SG1080110. The pUNI-TtrBACD plasmid was
generated by the introduction of ttrBACD from the synthetic
construct into pUNIPROM
17 on a BamHI-XbaI restriction
fragment. Subsequent derivatives were generated by removal of
one or more ttr genes using their flanking restriction sites
(Figure 1B). Other plasmids were generated by PCR ampli-
fication using oligonucleotide primers, the sequences and
details of which are supplied in Table S2. For analysis of signal
peptide function, the N-terminal 36 amino acids of TtrA
(“ssTtrA”) were expressed as an N-terminal genetic fusion to
mature (signal peptide-lacking) AmiA in pUNIPROM (pUNI-
ssTtrAAf-AmiA), to mature BlaM in pSUPROM (pSU-ssTtrAAf-
Bla), or to GFP with a C-terminal SsrA tag in pBAD24 (pBAD-
ssTtrAAf-GFP-SsrA). For concomitant arabinose-inducible
expression of TtrD, the synthetic ttrD gene was cloned into
pBAD33. For TtrD protein purification, the synthetic ttrD gene
was cloned into pETM-11 so as to allow IPTG-inducible
expression of TtrD with an N-terminal 6-His tag followed by a
TEV protease cleavage site (pETM-TtrD). For copurification
analysis, pQE80 based plasmids were constructed expressing
either His6-GST or a ssTtrA-GST fusion protein, with or
without the coexpression of untagged TtrD from the same
plasmid (each protein cloned with a similar E. coli optimized
ribosome binding site but both expressed from the vector T5
promoter). Plasmids for bacterial two-hybrid analyses were
constructed using the pUT18 and pT25 vectors.
20,21 TtrD was
fused to the C-terminus of T25 (pT25-TtrD) and ssTtrA fused
to the N-terminus of T18 (pUT18-ssTtrAAf). Single glutamine
substitutions were incorporated into pUT18-ssTtrAAf using the
Quikchange procedure according to the manufacturer instruc-
tions (Agilent Technologies). A. fulgidus DSM4303 genomic
DNA was kindly supplied by Clive S. Butler’s group (University
of Exeter, UK).
Expression and Production of Synthetic Gene Pro-
ducts. Expression of the ttrBACD genes from pUNI- plasmids
can be controlled by the T7 promoter. E. coli strain K-38 was
cotransformed with pGP1-2 (KanR), coding for the T7 RNA
polymerase, and a pUNI-vector encoding the gene(s) of
interest.
22 Synthesis of gene products was induced by heat
shock followed by radiolabeling with 35S methionine.
22 Proteins
were separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) before gels were fixed in 50%
(v/v) methanol and 10% (v/v) acetic acid and analyzed by
autoradiography.
Protein−Protein Interaction Analysis. BL21(DE3) and
BL21(DE3)Δtat were transformed with pQE80-GST-ssTtrA or
pQE80-GST-ssTtrAAf_ TtrD1 and expression of the GST fu-
sion protein induced with 1 mM IPTG overnight at 19 °C. Cells
were harvested and solubilized in B-Per (Pierce) containing
protease inhibitors (Roche). GST fusion proteins were then
isolated from the clarified bacterial extract by incubation (1 h,
4 °C) using glutathione Sepharose beads (GE Healthcare). The
beads were washed three times with 20 mM HEPES pH 7.4,
1 M NaCl, 1 mM DTT, and 0.1% (v/v) Triton X-100. Finally,
bound proteins were released from the beads by the addition of
sample buffer (1.6% (w/v) SDS, 50 mM Tris·HCl pH 6.8,
1.6 mM EDTA, 8% (v/v) glycerol, bromophenol blue) and
visualized by SDS-PAGE and Coomassie staining. Copurifying
proteins were identified by LC MS-MS (FingerPrints
Proteomics Facility, University of Dundee).
Bacterial two-hybrid analyses were performed according
to that described by Karimova and co-workers
20,21 using the
pUT18 and pT25 complementary pair of vectors. E. coli
reporter strain BTH101 was transformed with pUT18-ssTtrAAf
(or derivative/control) and pT25-TtrD (or control), and the
color of the resulting transformants scored on MacConkey
media with 0.2% maltose (positive result being red). For quan-
titative measurement of the interaction, β-galactosidase assays
were performed according to the method of Miller
23 on double-
transformed BTH101 grown to exponential phase (or in the
case of ssTtrA-RD and controls, to stationary phase) in LB and
permeabilized with toluene. Assays were performed on at least
three independent transformants.
Protein Purification. His6-TtrD was overproduced from
plasmid pETM-TtrD in E. coli BL21 (DE3) pLysS, and cells
were harvested and broken in the presence of protease inhi-
bitors (Calbiochem cocktail III). His6-TtrD was isolated from
the soluble fraction by immobilized metal affinity chromatog-
raphy (IMAC) using a HiTrap (GE Healthcare) chelating
column (20 mM Tris·HCl pH 7.5, 150 mM NaCl, 1 mM DTT,
25−500 mM imidazole). The His6 tag was removed by TEV
protease treatment (overnight digestion at room temperature in
buffer: 50 mM Tris·HCl pH 7.5, 0.5 mM EDTA, 10% (v/v)
glycerol, 2 mM DTT) and then noncleaved His-TtrD and TEV
protease removed by reverse IMAC. Untagged TtrD was
further purified using a Superdex 200 26/60 size-exclusion
column (GE Healthcare) equilibrated with 50 mM Tris·HCl
pH 7.5, 250 mM NaCl. The protein eluted as a single species
with a mass consistent with that of a monomer. Selected
fractions were pooled and concentrated to ∼40 mg mL−1
(2 mM) for crystallization trials. Sample purity was assessed by
SDS-PAGE. The protein concentration was determined
spectrophotometrically using a theoretical extinction coefficient
of 13 410 M−1 cm−1.
Crystallization and Data Collection. Initial crystallization
trials were performed using sitting drop vapor diffusion with
standard sparse matrix screens and set up using a Rigaku
Phoenix automated system. Equimolar amounts of a synthetic
peptide (DFIKGLVAVGS) and 5 mM GMP-PNP were added
to the protein prior to setting up crystallization experiments.
Numerous conditions gave small crystals and optimization of
selected conditions using hanging drop vapor diffusion then
yielded diffraction quality crystals in three distinct forms from
one (form I) previously deposited in the PDB (2idg). Crystal
form II was obtained with 0.2 M potassium formate, 20% (w/v)
PEG 3350 as the reservoir solution; form III with 0.1 M CHES
pH 9.5, 20% (w/v) PEG 8K and form IV 4.3 M NaCl, 0.1 M
HEPES pH 7.5. In each case crystals were obtained from drops
containing 1 μL of protein and 1 μL of reservoir, at room
temperature. Crystal forms II and III were obtained after the
protein−peptide mix had been incubated on ice; crystal form
IV was obtained when the mixture was heated to 70 °C. This
resulted in some precipitation of the sample that had to be
removed by centrifugation prior to crystallization. Crystals were
flash cooled in liquid nitrogen, mounted on a goniostat, and
maintained at −173 °C in a flow of cold nitrogen, and diffrac-
tion properties were characterized with a Rigaku Micromax 007
rotating anode R-AXIS IV+2 image plate system. For crystal
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Synchrotron Radiation Facility (Grenoble, France) on beamline
ID29. The diffraction data for form III were collected in-house;
however, due to a hardware fault, they are only 90% complete.
Data were integrated using XDS (forms III and IV
24) and
iMosflm (form II
25) and scaled with SCALA.
26 Crystallographic
statistics are presented in Table S3. Coordinates for the three
new crystal forms have been deposited in the PDB under
accession codes 2xol, 2yjm, and 2y6y.
Structure Solution and Refinement. Each structure was
solved by molecular replacement using PHASER.
27 For crystal
form II, a model was generated from PDB entry 2idg (referred
to as crystal form I). The structures of the other forms were
solved using the refined monomer from form II. Rounds of
model adjustment using Coot
28 interspersed with refinement
calculations with Refmac5
29 were used to complete the protein
model; the addition and refinement of water molecules and
components of the crystallization mixture (1,2-ethanediol,
N-cyclohexyl-2-aminoethanesulfonate, or Cl−) then completed
the refinement. Translation/libration/screw (TLS) refinement
using three domains (analysis was completed using the TLS
server
30) was performed for crystal form IV and two domains
for form III. Anisotropic thermal parameters were refined for
form II. Despite the inclusion of a peptide in crystallization
experiments, the electron density maps did not reveal any
evidence for ordered binding.
■ RESULTS
A Synthetic Operon Encoding a Putative Tat-Dependent
Tetrathionate Reductase. The genome of hyperthermo-
philic archaeon A. fulgidus encodes a putative tetrathionate
reductase (Figure 1A). The genes in question are Af0157−
Af0159, but for ease of understanding here, and in agreement
with the Salmonella nomenclature,
31 these have been renamed
ttrBCA here (Figure 1A). A. fulgidus TtrA (1134 residues) is
predicted to bear a twin-arginine signal peptide at its N-
terminus and shares 30% overall sequence identity with the
Salmonella TtrA protein (1020 residues). TtrA is therefore the
putative catalytic subunit containing an N-terminal [4Fe−4S]
cluster and a cysteine ligand (C297) to the metal component of
a pterin cofactor. The Salmonella TtrA is known to utilize
molybdopterin guanine dinucleotide (MGD) at its active site in




2−) to thiosulfate (−S−SO3
− or
S2O3
2−) and so confers the ability to use this unusual sulfur
compound as a terminal electron acceptor during respiration.
31
A. fulgidus TtrB is predicted to bind four [4Fe−4S] clusters
and is most likely the electron-transfer partner of TtrA but
bears no signal peptide of its own, and TtrC is predicted to be a
membrane anchor/quinol dehydrogenase subunit containing
nine transmembrane domains (Figure 1C). The overall archi-
tecture of this enzyme is therefore predicted to be a Tat-
targeted heterodimer anchored to the extracytoplasmic side of
the membrane by the TtrC subunit (Figure 4C).
A key feature of the A. fulgidus ttr operon is the presence of a
gene encoding a putative Tat proofreading chaperone, TtrD
(Figure 1A). To begin to understand the role of TtrD in
assembly of tetrathionate reductase, a synthetic strategy was
applied. The A. fulgidus protein sequences (TtrA-D) were
“back-translated” into DNA sequence incorporating engineered
ribosome binding- and restriction enzyme recognition-sites and
biased toward E. coli codon usage (Figure 1B). The completely
synthetic DNA sequence was arranged as ttrBACD to allow
facile removal of each gene from the 3′ end and so leave the
catalytic dimer intact. The synthetic operon was cloned into the
E. coli expression vector pUNIPROM,
17 and derivatives devoid
of ttrAD, ttrB, ttrBC, and ttrD alone were prepared. Synthesis
of the synthetic gene products in E. coli was monitored by 35
S-methionine labeling in vivo (Figure 1D). The expression and
synthesis of TtrB and TtrC could be identified, especially
when the ttrA and ttrD genes were removed from the vector
(Figure 1D). TtrD could also be readily identified, though
it may be susceptible to proteolysis (Figure 1D). However, it is
clear from this experiment that the synthetic TtrA subunit is
very unstable when expressed in E. coli and becomes rapidly
fragmented (Figure 1D).
The A. fulgidus TtrA Signal Peptide Has Transport
Activity in E. coli. The putative twin-arginine signal peptide of
A. fulgidus TtrA shares 33% overall sequence identity, and 50%
overall sequence similarity, with the TtrA signal peptide from
Salmonella (over 30 amino acids). Given the close evolutionary
relationship between Salmonella and E. coli, the A. fulgidus TtrA
signal peptide was tested for Tat transport activity in E. coli
(Figure 2).
One of the most sensitive in vivo Tat-transport assays avail-
able involves the Tat-dependent targeting of the amidase AmiA
to the bacterial periplasm.
32 An E. coli strain lacking periplasmic
Tat-dependent amidases (MCDSSAC) cannot grow in the
presence of 2% (w/v) SDS (Figure 2A) as the protective barrier
of the cell envelope is weakened.
32 However, this pheno-
type can be complemented by providing a Tat-targeted amidase
(e.g., AmiA) in trans. In this work the mature E. coli AmiA
enzyme was genetically fused to the A. fulgidus TtrA N-
terminus (residues 1−36). When this fusion was expressed in
MCDSSAC, it was observed to restore the ability of the strain
to grow in the presence of SDS (Figure 2A). This demonstrates
that the N-terminal region of TtrA contains an active twin-
arginine signal peptide that can direct AmiA to the E. coli
periplasm.
This finding was corroborated with a second in vivo Tat-
transport assay. E. coli is normally sensitive to the antibiotic
ampicillin unless a periplasmic β-lactamase (Bla) is expressed.
The Bla catalytic domain can be exported in a Tat-dependent
manner.
33 In this case the A. fulgidus TtrA signal peptide was
genetically fused to Bla and the ability of this fusion to confer
resistance to ampicillin tested (Figure 2B). Production of the
TtrA signal peptide-Bla fusion was indeed able to confer
ampicillin resistance on E. coli (Figure 2B), and this phenotype
was completely abolished in a Tat transport mutant (Figure 2B).
TtrD Interacts Directly with the TtrA Signal Peptide.
TorD family chaperones are renowned for their ability to bind
directly to twin-arginine signal peptides or inactive remnants of
such peptides.
10,34 To assess the ability of TtrD to bind to the
TtrA signal peptide, small-scale copurification experiments were
designed (Figure 3). The TtrA Tat signal peptide (residues
1−36) was genetically fused to the N-terminus of glutathione-S-
transferase (GST) and expressed alone, or in the presence of
TtrD, in E. coli (Figure 3). The GST was then isolated using
glutathione beads and copurifying proteins identified following
SDS-PAGE and mass spectrometry (Figure 3). It is clear from
these experiments that TtrA-GST copurified with a single pro-
tein, which was unambiguously identified as A. fulgidus TtrD
(Figure 3). No endogenous E. coli Tat proofreading chaper-
ones, or any other E. coli proteins, were found to interact with
TtrA-GST. Interestingly, the amount of copurifying TtrD was
enhanced by coexpression of TtrA-GST in a Δtat mutant
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gel suggests that the full-length TtrA signal peptide-GST fusion
is less susceptible to proteolysis when expressed in the E. coli
Δtat strain (Figure 3) and that this probably accounts for the
increased amounts of TtrD protein that can be copurified from
this genetic background.
To further corroborate the binding between TtrD and the
TtrA Tat signal peptide, an E. coli-based bacterial two-hybrid
(BTH) system
20 was employed. This adenylate cyclase-based
method works exceptionally well for detecting chaperone−Tat
signal peptide interactions,
12,17 and fusion of TtrD to the T25
domain, and the TtrA signal peptide (TtrA amino acids 1−36)
to the T18 domain, of the adenylate cyclase used in the BTH
reporter system showed a clear positive interaction between the
two proteins (Figure 4B).
Next, an assay was performed in order to assess whether the
TtrD protein retained physiological activity when interacting
with the TtrA signal peptide. An interesting observation for E.
coli TorD was that overproduction of this proofreading chaper-
one could enhance the Tat-dependent export of a fusion be-
tween the TorA signal peptide and green fluorescent protein
(GFP).
35 To reconstruct this assay for the A. fulgidus system
under investigation here, a plasmid was constructed encoding a
fusion between the TtrA signal peptide and GFP bearing an
SsrA tag (Figure 2C). An SsrA tag is a short C-terminal
sequence (...AANDENYALAA-COOH) that will target any
protein for degradation by cytoplasmic proteases.
36 However,
transport of an SsrA tag-containing protein to the periplasm
protects it from degradation and in the case of Tat-dependent
targeting of GFP-SsrA therefore leads to an increase in GFP
fluorescence in a tat+ strain compared to a tat mutant.
36 In this
work, production of the ssTtrA-GFP-SsrA fusion alone in Tat-
active E. coli led to a very low level of fluorescence, pointing to
a rate of export for this fusion protein that is too slow to escape
proteolytic degradation (Figure 2C). However, coexpression of
TtrD with the ssTtrA-GFP-SsrA fusion protein in the same
strain lead to a clear increase in cellular GFP fluorescence
(Figure 2C). This TtrD effect was not evident in a tat− back-
ground (Figure 2C), which taken together suggests the func-
tional interaction between the chaperone and the signal peptide
can enhance the rate or efficiency of transport of GFP-SsrA on
the Tat pathway.
Collectively, these experiments demonstrate that TtrD is a
signal peptide-binding protein and that at least one of its
binding partners in A. fulgidus is the Tat-targeted reductase
with which it is coexpressed.
Figure 3. Interaction of TtrD with the TtrA signal peptide in vivo. The
ssTtrAAf-GST fusion protein was expressed either alone (from plasmid
pQE80-ssTtrAAf-GST) or together with TtrD (from plasmid pQE80-
ssTtrAAf-GST_TtrD1) in either tat mutant or parental strain E. coli
BL21(DE3). As a control, His6-GST was coexpressed with TtrD
(plasmid pQE80-GST-TtrD1). GST fusion proteins were affinity
purified and isolated proteins visualized by SDS-PAGE and Coomassie
staining. The protein copurifying protein with ssTtrAAf-GST was
identified as TtrD (AF0160) by mass spectrometry. Molecular weight
standards (M) are indicated.
Figure 2. The N-terminus of TtrA contains an active twin-arginine
signal peptide. (A) SDS-resistance (Tat-dependent amidase export)
assay. Parental strain (WT) or amiAC mutant E. coli (strains MC4100
and MCDSSAC, respectively) carrying pUNIPROM (pUNI, vector
control) or pUNI-ssTtrAAf-AmiA (expressing an ssTtrAAf-AmiA fusion
protein) were grown aerobically on LB plates containing 2% (w/v)
SDS where indicated. (B) Tat-dependent β-lactamase (Bla) transport
assay. Parental strain (WT) or tatABCD mutant (tat−) E. coli (strains
MC4100-A and DADE-A, respectively) were transformed with a
plasmid encoding the A. fulgidus TtrA signal peptide fused to signal-
less β-lactamase (pSU-ssTtrAAf-Bla) and a vector encoding TtrD
(pBAD-TtrD). Control plasmids were pSUPROM (pSU) and
pBAD33 (pBAD). Overnight cultures of each strain were diluted
10−4 and 10 μL spotted onto an LB plate supplemented with Kan
(50 μg/mL), Cm (25 μg/mL), Amp (6 μg/mL), and L-arabinose
(0.2% w/v). (C) TtrD enhances the transport activity of the TtrA
signal peptide. E. coli strains MC4100-A (WT) and DADE-A (tat−)
were each transformed with pBAD-ssTtrAAf-GFP-SsrA (or vector
control pBAD24) and pBAD-TtrD (or vector control pBAD33) and
grown aerobically in LB containing Amp (100 μg/mL), Cm (25 μg/
mL), and arabinose (0.2% w/v). GFP fluorescence was measured after
18 h. The fluorescence for each strain carrying pBAD-ssTtrAAf-GFP-
SsrA is expressed relative to the background fluorescence of the parent
strain carrying the vector control plasmids. Bars show mean ± SEM.
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Signal Peptide. The BTH system was exploited in order to
focus in on the minimum TtrD binding epitope within the TtrA
signal peptide. The plasmid encoding the TtrA signal peptide-
T18 fusion was modified to produce four truncated forms,
A−D (Figure 4A). Region A comprised residues 1−26 of the
TtrA signal peptide, and this showed similar binding to TtrD
in vivo as the full length signal peptide (Figure 4B). However,
constructs producing both region B (residues 10−27) and
region C (residues 11−36) were essentially unable to interact
with TtrD in this assay (Figure 4B). This suggested
immediately that the binding epitope for TtrD on this peptide
lay toward the N-terminus.
Next, site-directed mutagenesis was employed to narrow
down the TtrD binding epitope still further. Glutamine residues
are among the least common to be found in twin-arginine
signal peptides in general.
37 Here, TtrA residues R6, V15, S17,
V20, L22, and G24 were substituted by glutamine (Figure 4A)
and their ability to interact with TtrD assessed by BTH
(Figure 4C). Of the six variants tested, only the V15Q
substitution was found to interfere with TtrD binding in vivo
(Figure 4C). Substitution of the highly conserved R6 from the
targeting motif with glutamine had no impact on TtrD binding
(Figure 4C). This new knowledge was then used to design a
BTH construct producing only region D of the TtrA signal
peptide (Figure 4A), which was observed to interact strongly
with TtrD in vivo (Figure 4B).
Taken together, this systematic truncation and site-specific
mutagenesis approach was successful in identifying TtrA signal
peptide residues 7−17 as being sufficient for TtrD recognition.
Crystal Structure of A. fulgidus TtrD. The TtrD protein
was overproduced and purified, and attempts were made to
determine a structure of the complex with a TtrA signal pep-
tide. However, crystallization experiments with either the 27-
mer region A (Figure 4) or shorter 11-mer region D binding
epitope identified in this work (Figure 4) were unsuccessful.
The crystallization trials rather produced three new crystal
forms of ligand-free TtrD distinct from that previously obtained
by a structural genomics consortium (PDB entry 2idg, crystal
form I). The new crystal forms provide a significant improve-
ment in the resolution of the structure of TtrD, from 2.7 to
1.35 Å. The enhanced resolution has allowed an improvement
in overall accuracy and the correction of erroneous side chain
orientations found in the original deposition. The analyses also
enabled an investigation regarding whether intermolecular
interactions in the crystal lattice influenced the protein
structure. The four crystal forms of TtrD that are now available
present seven individual molecular structures. Least-squares
fitting of the different structures, ∼160 Cα atoms, results in a
range of RMSDs from 0.36 to 1.11 Å with an average of 0.7 Å.
These data, and structural overlays (data not shown), indicate
that the structures are similar irrespective of the crystalline
environment in which they have been determined and it is
therefore only necessary to describe a generic TtrD structure.
The TtrD molecule is a globular, single-domain protein of
dimensions approximately 35 × 43 × 45 Å. There are nine
α-helices, with α1, α7, α8, and α9 forming a four-helix bundle
(Figure 5A). TtrD represents an archetypal thermophilic
protein displaying features noted as contributing to enhanced
stability (reviewed by Zhou et al.
38). The protein contains a
pronounced hydrophobic core, formed by a number of aro-
matic residues (eight phenylalanines and three tyrosines),
which almost surrounds the N-terminal segment of α8. There
are 51 polar residues, 28 basic and 23 acidic, in the crystallo-
graphic model. These residues form eight salt bridge
interactions plus, at numerous positions, hydrogen-bonding
networks to main chain functional groups that help to hold the
polypeptide in a tight globular fold with no extended loop
structures.
A search of the PDB using the Dali server
39 identified two
orthologous structures worthy of comment: the E. coli DmsD
Tat proofreading chaperone
15 (PDB entry 3efp, Z-score
10.4, rmsd 2.7 Å for overlay of 120 Cα positions) and the
low-resolution structure of A. fulgidus NarJ
40 (PDB entry 2o9x,
Z-score 9.2, rmsd 3.1 Å for overlay of 123 Cα positions). The
overall sequence identity shared between TtrD with these two
proteins is only 17 and 21%, respectively, and structural over-
lays primarily align the four-helix bundles (data not shown).
Collectively, the three structures suggest that a small, stable,
Figure 4. Analysis of the TtrD-TtrA signal peptide interaction using a
bacterial two-hybrid assay. (A) Schematic figure depicting the full-
length A. fulgidus TtrA twin-arginine signal peptide and positions of
truncations (regions A−D) and glutamine substitutions (indicated by
an asterisk) tested in the two-hybrid system. The twin-arginine motif is
underlined. (B) The bacterial two-hybrid system of Karimova et al. was
used to measure the in vivo interaction between TtrD and full-length
TtrA signal peptide (WT) and truncated versions. (C) The bacterial
two-hybrid system was used to measure the in vivo interaction between
TtrD and variants of the TtrA signal peptide bearing single glutamine
substitutions. In all assays TtrD was fused to the T25 fragment of
adenylate cyclase, and the signal peptide variants were fused to T18.
Output from the two-hybrid system was detected as β-galactosidase
activity and expressed as a percentage of the native interaction. Bars
show mean ± SEM.
Biochemistry Article
dx.doi.org/10.1021/bi201852d | Biochemistry 2012, 51, 1678−1686 1683globular and α-helical protein fold has evolved for a peptide-
binding role.
■ DISCUSSION
MGD-dependent tetrathionate reductases are an important
family of respiratory enzymes, and the subcellular localization is
critical to their physiological function, since the substrate is likely
to be membrane impermeable. Indeed, tetrathionate is normally
produced outside the prokaryotic cell by, most commonly,
an animal host during bacterial infection.
19 As a result, genes for
similar tetrathionate reductases can be identified in bacterial
opportunistic pathogens, for example, Salmonella, Proteus
mirabilis, Bordetella parapertussis, Serratia marcescens, and now
also in the archaeon A. fulgidus. In all cases the enzymes are
predicted to have similar architectures and topologies (e.g.,
Figure 1C) and assembly of such Tat-dependent and MGD and
[Fe−S] cluster-binding enzymes would be expected to require a
Tat proofreading chaperone. For example, the broadly similar
heterodimeric DMSO reductase (DmsAB) from E. coli and
Salmonella requires a TorD family chaperone (DmsD) for its
correct assembly.
14,41 However, subtle but interesting differ-
ences can be observed. DmsA is a member of the “type II”
molybdoenzymes
42 that contain an active-site serine or
aspartate ligand to the metal. Most Type II enzymes that
have been studied (NarG-type nitrate reductases, DMSO/
TMAO reductases, selenate reductases) require, and are usually
coexpressed with, a TorD family chaperone for correct
assembly. On the other hand, tetrathionate reductase is a
“type I” molybdoenzyme, which is a family of enzymes bearing
cysteine or selenocysteine as active site metal ligands including
the Nap-like periplasmic nitrate reductases, the respiratory
formate dehydrogenases, and thiosulfate reductases.
42 The
Type I nitrate reductases require the activity of the NapD
family of signal-peptide-binding proteins for assembly, which
bears no relationship at all with the TorD family.
43 The type I
formate dehydrogenases do not normally require a TorD family
chaperone for assembly either, save for one example in
Campylobacter jejuni.
44 However, in this particular case the
formate dehydrogenase seems to have acquired a (type II)
selenate reductase-like signal peptide and its cognate binding
protein in a natural gene-shuffling event. It was a surprise,
therefore, to find ttrD located at the 3′ end of the ttrBCA
operon in A. fulgidus, especially as the signal peptide itself was
closely related to that of Salmonella TtrA, and none of the
tetrathionate operons from pathogenic bacteria are clustered
with a gene encoding a TorD family chaperone. Does the
Salmonella tetrathionate reductase require a TorD family
chaperone for activity? This work on the A. fulgidus system
would imply strongly that it does, and our preliminary experi-
ments in this area suggest that Salmonella DmsD, as well as the
uncharacterized TorD family protein STM0610, have roles to
play in tetrathionate reductase assembly in that bacterium
(Guymer, D., and Sargent, F., unpublished).
In this work TtrD was found to bind directly to the TtrA
signal peptide. The 11-residue TtrD binding epitope on TtrA is
close to, but does not include, the conserved arginines that
would be essential for protein export (Figure 4). This is an
important observation because any chaperone binding motif
completely reliant on these conserved arginines would
immediately reduce the specificity of the peptide−chaperone
interaction, and to date a general Tat chaperone that will
recognize all Tat substrates in a given organism has never been
identified. Indeed, despite the conservation of critical residue
V15 in both A. fulgidus and Salmonella TtrA, the TtrD chaper-
one was unable to bind to the Salmonella TtrA signal peptide
(data not shown), suggesting that TtrD is not a promiscuous
signal-binding protein but specific for its natural partner. The
location of the binding epitope near the N-terminus of the TtrA
signal peptide was a surprise, however, as the E. coli TorD
protein has been shown to bind to its cognate signal peptide at
the C-terminus, well away from the conserved Tat motif.
12
Figure 5. Crystal structure of TtrD. (A) A cartoon representation of
the TtrD secondary structure. The four-helix bundle is yellow, the
hinge region is blue, and peripheral helices red. (B) The functionally
important His90 side-chain interacts (van der Waals) with the highly
conserved Phe20. The functionally important Asp89 forms a salt
bridge with Arg52 in the ligand-free structure and forms hydrogen
bonds with Ser54. Arg52 may also interact with the nonconserved
His87 from the hinge region. (C) The position of two hydrophobic
patches on the surface of TtrD that could represent peptide binding
sites. The protein is shown as a semitransparent van der Waals surface,
and secondary structure is depicted as in panel A.
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twin-arginine signal peptides in more detail will require addi-
tional structural information. The interdomain “hinge” region
noted previously in TorD family proteins,
16 consensus
EPxDH,
45 corresponds to the sequence stretch Leu86-
His-Ala-Asp-His90 in TtrD. Unlike many other structures for
TorD family proteins, this region is very well-defined in the
TtrD structure. This pentapeptide forms a turn linking a region
of extended structure after helix α6 with helix α7. These poly-
peptide segments form a similar structure in DmsD but are
displaced relative to each other in the least-squares alignment
due to a difference in the length of TtrD α6 (data not shown).
In both DmsD and TtrD the conserved aspartate (Asp89 in
TtrD) makes hydrogen-bonding interactions with a conserved
glycine-serine unit (Gly53-Ser54 in TtrD). The acidic side
chain accepts hydrogen bonds donated from the serine amide
and hydroxyl groups, and the aspartate main chain carbonyl
accepts a hydrogen bond from the glycine amide. These
interactions serve to connect the hinge to the α3/α4 section on
the surface of the protein (Figure 5B). In TtrD the Asp89 side
chain also makes a hydrogen bond with the side chain of Arg52,
further stabilizing this part of the protein structure. His90 is
tucked down into a hydrophobic pocket near helices α1 and α3.
The side chain donates and accepts hydrogen bonds with the
Val48 carbonyl and Ala92 amide. Despite reference to this
stretch of polypeptide as the “hinge”, it should be noted that
TtrD cannot be correctly referred to as a “two-domain” protein.
Rather, TtrD is clearly a globular, single domain, built around a
central four-helix bundle.
There is no obvious, clearly defined peptide binding cleft on
the surface of TtrD. It is clear that the Tat signal peptide bind-
ing epitope does not include the conserved arginine pair and
instead possesses significant hydrophobic character. Therefore,
an inspection of the TtrD structure was carried out to identify
potential complementary features on the surface of the protein.
Two hydrophobic patches are noted on either side of the con-
served hinge segment. First, about 15 Å distant is a patch
formed by residues on helices α3 and α4 and the turn linking
helices α8 and α9. In particular, Leu47, Leu51, Val55, Leu56,
and Pro140 contribute to forming a hydrophobic surface.
On the other side of the hinge, closer at about 10 Å, residues
from α5a n dα7 (Pro61, Leu64, Val67, Val71, Phe75, His131,
Pro134) form a potential Tat substrate-binding site (Figure 5C).
This second hydrophobic patch occupies a similar position on
the TtrD surface as a hydrophobic patch on the surface of
DmsD, which is made from Leu82, Pro86, Trp87, and Pro124
(data not shown). Although the two protein structures are very
different in this area, the conservation of a hydrophobic surface
is intriguing. Indeed, DmsD Pro86 was found to be important
for the signal peptide interaction, with a Pro86Gln variant
having significantly impaired signal peptide binding activity.
18
Moreover, a DmsD Trp87Tyr variant was found to bind the
DmsA signal peptide more tightly in vitro, also suggesting this
residue has a role to play in signal recognition.
18 Further work
will be required to investigate these two potential substrate-
binding sites.
Concluding Remarks. Although archaea clearly utilize the
Tat pathway for transport of folded proteins similar to bac-
teria,
46 this work now demonstrates that Tat proofreading
systems are also at work in these normally extremophilic
organisms. It is anticipated that the structural breakthroughs
described here will lead to a greater understanding of the mech-
anism of signal peptide recognition on the Tat pathway.
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